Articles related to PAIN MANAGEMENT

Misunderstandings and misperceptions about migraine persist, leading to misdiagnosis and less-than-optimal management. In this video, migraine experts seek to update the primary care provider on the current understanding of the disease, and the role of gepants, ditans, triptans, calcitonin gene-related peptide antibodies, and other therapies.

This broad review of recent studies in women’s health topics aims to help the primary care physician in discussing and guiding therapy for women in topics from cardiovascular disease to pelvic pain. The review covers such questions as: How does migraine with aura affect CVD risk in women? How do you respond to patient questions about fracture risk and bisphosphonates? Are antidepressants safe for women who are considering pregnancy? Is gabapentin effective for chronic pelvic pain?

Neurology referrals for headache are often unnecessary and delay appropriate headache care. A Geisinger Medical Center neurologist developed a tool that pops up on the EMR when the diagnosis of headache is entered. It guides with questions and suggested medications. The tool was developed in response to a chart review showing that referrals for headache from PCPs did not regularly document enough data in their notes on headache to reach a viable diagnosis nor were they regularly trying medications before referring.

Gabapentin has been increasingly used as part of a multimodal analgesia regimen to reduce opioid use in perioperative pain management. In this cohort study of 237,872 adults aged 65 years or older, perioperative gabapentin users had significantly increased risk of delirium, new antipsychotic use, and pneumonia compared with nonusers after major surgery.

The colorful fentanyl, known as “rainbow fentanyl,” has been identified in 18 different states and has been found in a variety of forms, including pills, powder, and blocks that resemble sidewalk chalk, according to a press release from the agency. No particular color has been found to have a higher potency through testing. According to the DEA, every shade, shape, and size should be viewed as being exceedingly harmful.

57-year-old man, otherwise healthy 2 month history of recurrent abdominal pain with diarrhea A history of celiac disease that had been well controlled with a gluten-free diet 5-pound unintentional weight loss since the onset of symptoms Tissue IgA > 30x over nl What conditions would you consider in your evaluation?